Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nephros (NEPH) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to $2.6 million.

  • Nephros' Operating Expenses rose 3386.52% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.9 million, marking a year-over-year increase of 720.55%. This contributed to the annual value of $8.7 million for FY2024, which is 1281.26% down from last year.
  • As of Q3 2025, Nephros' Operating Expenses stood at $2.6 million, which was up 3386.52% from $2.5 million recorded in Q2 2025.
  • Over the past 5 years, Nephros' Operating Expenses peaked at $2.7 million during Q4 2023, and registered a low of $1.9 million during Q3 2024.
  • Moreover, its 5-year median value for Operating Expenses was $2.4 million (2021), whereas its average is $2.4 million.
  • Its Operating Expenses has fluctuated over the past 5 years, first crashed by 1917.6% in 2024, then skyrocketed by 3386.52% in 2025.
  • Over the past 5 years, Nephros' Operating Expenses (Quarter) stood at $2.2 million in 2021, then grew by 0.46% to $2.2 million in 2022, then increased by 21.25% to $2.7 million in 2023, then fell by 19.18% to $2.2 million in 2024, then grew by 20.53% to $2.6 million in 2025.
  • Its last three reported values are $2.6 million in Q3 2025, $2.5 million for Q2 2025, and $2.6 million during Q1 2025.